Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Arrhythmias

  Free Subscription


09.09.2019

4 Am J Cardiol
1 Ann Thorac Surg
2 Circulation
3 Clin Cardiol
1 Heart
4 Int J Cardiol
8 J Am Coll Cardiol
1 J Cardiol
2 J Cardiovasc Electrophysiol
1 J Interv Card Electrophysiol
1 J Thromb Thrombolysis
2 Lancet
2 N Engl J Med
4 Pacing Clin Electrophysiol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. TANIGUCHI N, Miyasaka Y, Suwa Y, Harada S, et al
    Usefulness of Left Atrial Volume as an Independent Predictor of Development of Heart Failure in Patients With Atrial Fibrillation.
    Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30880.
    PubMed     Text format     Abstract available

  2. AN Y, Ogawa H, Esato M, Ishii M, et al
    Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry).
    Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30879.
    PubMed     Text format     Abstract available

  3. SAIRENCHI T, Yamagishi K, Iso H, Irie F, et al
    Age-Specific Impact of Atrial Fibrillation on Cardiovascular Mortality Among Japanese Men and Women (The Ibaraki Prefectural Health Study [IPHS]).
    Am J Cardiol. 2019 Aug 8. pii: S0002-9149(19)30878.
    PubMed     Text format     Abstract available

  4. GOLDSTEIN SA, Green J, Huber K, Wojdyla DM, et al
    Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial).
    Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30877.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. TAKAGAKI M, Yamaguchi H, Ikeda N, Yamakage H, et al
    Risk factors for atrial fibrillation recurrence post Cox-maze IV performed without pre-exclusion.
    Ann Thorac Surg. 2019 Aug 28. pii: S0003-4975(19)31238.
    PubMed     Text format     Abstract available


    Circulation

  6. AL-KHATIB SM, Kusumoto FM
    Implantable Cardioverter Defibrillators Have Stood the Test of Time!
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043354.
    PubMed     Text format    

  7. SCHRAGE B, Uijl A, Benson L, Westermann D, et al
    Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043012.
    PubMed     Text format     Abstract available


    Clin Cardiol

  8. WILLY K, Dechering DG, Wasmer K, Kobe J, et al
    Outcome of catheter ablation of supraventricular tachyarrhythmias in cardiac sarcoidosis.
    Clin Cardiol. 2019 Sep 3. doi: 10.1002/clc.23263.
    PubMed     Text format     Abstract available

  9. WARDEN BA, Diep C, Ran R, Thomas M, et al
    The effect of heparin infusion intensity on outcomes for bridging hospitalized patients with atrial fibrillation.
    Clin Cardiol. 2019 Sep 4. doi: 10.1002/clc.23256.
    PubMed     Text format     Abstract available

  10. TOMASDOTTIR M, Friberg L, Hijazi Z, Lindback J, et al
    Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation.
    Clin Cardiol. 2019 Sep 6. doi: 10.1002/clc.23257.
    PubMed     Text format     Abstract available


    Heart

  11. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    PubMed     Text format     Abstract available


    Int J Cardiol

  12. ISNARD R, Pousset F
    Left bundle branch block-induced cardiomyopathy: Myth or reality?
    Int J Cardiol. 2019 Aug 24. pii: S0167-5273(19)33847.
    PubMed     Text format    

  13. PROIETTI M
    Managing thromboembolic risk in patients with subclinical atrial fibrillation: A new challenge for the clinical cardiologist.
    Int J Cardiol. 2019 Aug 28. pii: S0167-5273(19)33534.
    PubMed     Text format    

  14. CASTRO HEVIA J, Dorantes Sanchez M, Martinez Lopez F, Castaneda Chirino O, et al
    Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome.
    Int J Cardiol. 2019;277:130-135.
    PubMed     Text format     Abstract available

  15. BREITENSTEIN A, Sawhney V, Providencia R, Honarbakhsh S, et al
    Ventricular tachycardia ablation in structural heart disease: Impact of ablation strategy and non-inducibility as an end-point on long term outcome.
    Int J Cardiol. 2019;277:110-117.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  16. GUO Y, Wang H, Zhang H, Liu T, et al
    Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.
    J Am Coll Cardiol. 2019 Aug 22. pii: S0735-1097(19)36365.
    PubMed     Text format     Abstract available

  17. HIRAM R, Naud P, Xiong F, Al-U'datt D, et al
    Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.
    J Am Coll Cardiol. 2019;74:1332-1347.
    PubMed     Text format     Abstract available

  18. KOTTKAMP H
    On the Atrial Fibrillation Substrate: From the "Unknown Species" to Deeper Insights Into Pathophysiology.
    J Am Coll Cardiol. 2019;74:1348-1351.
    PubMed     Text format    

  19. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    PubMed     Text format     Abstract available

  20. PHILLIPS RA, Arnold RM, Peterson LE
    Hypertension Guidelines: The Threads That Bind Them.
    J Am Coll Cardiol. 2018;72:1246-1251.
    PubMed     Text format    

  21. ALOIA E
    DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2092-2093.
    PubMed     Text format    

  22. YE ZL, Guo WQ, Li L
    Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?
    J Am Coll Cardiol. 2018;72:2093.
    PubMed     Text format    

  23. JI-YOUNG LEE C, Torp-Pedersen C
    Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2093-2094.
    PubMed     Text format    


    J Cardiol

  24. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Text format     Abstract available


    J Cardiovasc Electrophysiol

  25. NAKASHIMA T, Takasugi N, Sahashi Y, Hatasa M, et al
    Cardiac memory-related QT prolongation during right bundle-branch block in a patient with pre-existing left bundle-branch block.
    J Cardiovasc Electrophysiol. 2019 Sep 2. doi: 10.1111/jce.14133.
    PubMed     Text format    

  26. KATSUMATA Y, Tamura Y, Kimura T, Kohsaka S, et al
    A High BNP Level Predicts an Improvement in Exercise Tolerance after a Successful Catheter Ablation of Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2019 Aug 31. doi: 10.1111/jce.14149.
    PubMed     Text format     Abstract available


    J Interv Card Electrophysiol

  27. DI C, Wan Z, Tse G, Letsas KP, et al
    The V1-V3 transition index as a novel electrocardiographic criterion for differentiating left from right ventricular outflow tract ventricular arrhythmias.
    J Interv Card Electrophysiol. 2019 Sep 2. pii: 10.1007/s10840-019-00612.
    PubMed     Text format     Abstract available


    J Thromb Thrombolysis

  28. WOJSZEL ZB, Kasiukiewicz A
    Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study.
    J Thromb Thrombolysis. 2019 Aug 30. pii: 10.1007/s11239-019-01937.
    PubMed     Text format     Abstract available


    Lancet

  29. VRANCKX P, Valgimigli M, Eckardt L, Tijssen J, et al
    Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)31872.
    PubMed     Text format     Abstract available

  30. CAPODANNO D, Angiolillo DJ
    Dual antithrombotic therapy for atrial fibrillation and PCI.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)31954.
    PubMed     Text format    


    N Engl J Med

  31. YASUDA S, Kaikita K, Akao M, Ako J, et al
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
    PubMed     Text format     Abstract available

  32. BECKER RC
    Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
    PubMed     Text format    


    Pacing Clin Electrophysiol

  33. ROMERO J, Briceno DF, Di Biase L
    NOACs Vs. warfarin during watchman implantation in patients with atrial fibrillation: The end of an era.
    Pacing Clin Electrophysiol. 2019 Sep 4. doi: 10.1111/pace.13797.
    PubMed     Text format    

  34. ROMERO J, Alviz I, Briceno DF, Zhang XD, et al
    Empirical Cavo-tricuspid isthmus line during ablation of atrial fibrillation: Enough is enough!
    Pacing Clin Electrophysiol. 2019 Sep 3. doi: 10.1111/pace.13798.
    PubMed     Text format    

  35. SABAR MI, Ara F, Henderson A, Ahmed O, et al
    A study to assess a novel automated electrocardiogram technology in screening for atrial fibrillation.
    Pacing Clin Electrophysiol. 2019 Sep 3. doi: 10.1111/pace.13800.
    PubMed     Text format     Abstract available

  36. LEE WC, Fang HY, Chen HC, Chen YL, et al
    Additional cavotricuspid isthmus block ablation may not improve the outcome of atrial fibrillation ablation.
    Pacing Clin Electrophysiol. 2019 Sep 3. doi: 10.1111/pace.13799.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: